In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

University of Vermont

http://www.uvm.edu/

Latest From University of Vermont

Deals Shaping The Medical Industry, April 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March 2015.

BioPharmaceutical Medical Device

Targacept Inc.

Targacept spun out in 2000 from tobacco giant RJ Reynolds, with 60 patents, 23 scientists and an ongoing strategic alliance with Aventis. Not to mention $30 million from venture backers excited about the company's potential for discovering drugs that act on neuronal nicotinic receptors.

Strategy
See All

Company Information

  • Industry
  • Academic and Research Institutions
UsernamePublicRestriction

Register